← Leaderboards
Edward N Janoff
Va Eastern Colorado Health Care System
$11,927,807
Attributed
$13,898,446
Total exposure
16
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,795,317 · 13
VA$0 · 4
By mechanism
R01$11,415,314 · 6
P30$3,896,871 · 1
R21$1,691,093 · 4
N01$792,039 · 2
I01$0 · 3
IS1$0 · 1
Top collaborators
- Katherine F Luzuriaga5 shared
- Alkesh Harihar Jani3 shared
Most similar at Va Eastern Colorado Health Care System
Same institution · by research overlap
- Alkesh Harihar Jani$807,046
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionImmunoglobulin AImmunoglobulin GAntibodiesPreventBacteriaSerumStreptococcus PneumoniaeCellsB-LymphocytesT-LymphocyteResponseAdultVaccinationPneumoniaVaccinesChildBacterial PneumoniaGenesImmunoglobulin MImmune ResponseProteinsCessation Of LifeMolecular
Grant awards (50)
Impaired B Cell and Vaccine Responses with Advance Renal Disease$0
I01 · FY2024 · VA
Impaired B Cell and Vaccine Responses with Advance Renal Disease$0
I01 · FY2023 · VA
Complementary Mechanisms of Protection Against Pneumococcal Infection$0
I01 · FY2022 · VA · contact PI
Impaired B Cell and Vaccine Responses with Advance Renal Disease$0
I01 · FY2022 · VA
Impact of HIV-1 and Aging on Mucosal Vaccine Responses$0
I01 · FY2021 · VA · contact PI
Complementary Mechanisms of Protection Against Pneumococcal Infection$0
I01 · FY2021 · VA · contact PI
Complementary Mechanisms of Protection Against Pneumococcal Infection$0
I01 · FY2020 · VA · contact PI
Complementary Mechanisms of Protection Against Pneumococcal Infection$0
I01 · FY2019 · VA · contact PI
ShEEP Request for Assuring Research Reproducibility with an Integrated Sample and Data Management System$0
IS1 · FY2019 · VA · contact PI
Impact of HIV-1 and Aging on Mucosal Vaccine Responses$0
I01 · FY2019 · VA · contact PI
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses$377,960
R01 · FY2018 · AI · contact PI
Impact of HIV-1 and Aging on Mucosal Vaccine Responses$0
I01 · FY2018 · VA · contact PI
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses$441,714
R01 · FY2017 · AI · contact PI
Impact of HIV-1 and Aging on Mucosal Vaccine Responses$0
I01 · FY2017 · VA · contact PI
HIV-1 Evolution and Functional Correlates of MTCT$767,192
R01 · FY2016 · AI
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses$462,455
R01 · FY2016 · AI · contact PI
HIV-1 Evolution and Functional Correlates of MTCT$781,056
R01 · FY2015 · AI
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses$462,794
R01 · FY2015 · AI · contact PI
HIV-1 Evolution and Functional Correlates of MTCT$790,290
R01 · FY2014 · AI
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses$543,677
R01 · FY2014 · AI · contact PI
HIV-1 Evolution and Functional Correlates of MTCT$753,856
R01 · FY2013 · AI
HIV-1 Evolution and Functional Correlates of MTCT$848,885
R01 · FY2012 · AI
Mucosal Determinants of HIV Infection of Infants by Breast Milk$526,136
R01 · FY2012 · HD · contact PI
Cross-serotype protection against Streptococcus pneumoniae by induction of neutra$191,250
R21 · FY2012 · AI · contact PI
Mucosal Determinants of HIV Infection of Infants by Breast Milk$555,859
R01 · FY2011 · HD · contact PI
Cross-serotype protection against Streptococcus pneumoniae by induction of neutra$229,500
R21 · FY2011 · AI · contact PI
Mucosal Determinants of HIV Infection of Infants by Breast Milk$540,625
R01 · FY2010 · HD · contact PI
Mucosal Immune Ontogeny and Intestinal Microbiota in Infants$208,539
R21 · FY2010 · AI · contact PI
Mucosal Determinants of HIV Infection of Infants by Breast Milk$573,650
R01 · FY2009 · HD · contact PI
Mucosal Immune Ontogeny and Intestinal Microbiota in Infants$249,352
R21 · FY2009 · AI · contact PI
Mucosal Mechanisms of Control of Influenza$155,127
R21 · FY2008 · AI · contact PI
Mucosal Mechanisms of Control of Influenza$279,325
R21 · FY2007 · AI · contact PI
U of Colorado Center for AIDS Research$1,963,883
P30 · FY2006 · AI · contact PI
Mucosal Defense vs Transmission of HIV by Breast Milk$321,558
R01 · FY2006 · HD · contact PI
U of Colorado Center for AIDS Research$1,932,988
P30 · FY2005 · AI
MUCOSAL DEFENSE BY IGA AGAINST S PNEUMONIAE$252,000
R01 · FY2005 · AI
Mucosal Defense vs Transmission of HIV by Breast Milk$177,707
R01 · FY2005 · HD
Mucosal Defense vs Transmission of HIV by Breast Milk$123,076
R01 · FY2005 · HD
Mucosal Defense vs Transmission of HIV by Breast Milk$268,911
R01 · FY2004 · HD
MUCOSAL DEFENSE BY IGA AGAINST S PNEUMONIAE$252,000
R01 · FY2004 · AI
Role of Tonsils in Induction of Mucosal Immune Responses$189,000
R21 · FY2004 · DE
Mucosal Defense vs Transmission of HIV by Breast Milk$333,878
R01 · FY2003 · HD
MUCOSAL DEFENSE BY IGA AGAINST S PNEUMONIAE$274,806
R01 · FY2003 · AI
Role of Tonsils in Induction of Mucosal Immune Responses$189,000
R21 · FY2003 · DE
MUCOSAL DEFENSE BY IGA AGAINST S PNEUMONIAE$296,052
R01 · FY2002 · AI
Mucosal Defense vs Transmission of HIV by Breast Milk$279,906
R01 · FY2002 · HD
INTERFERON AND HOST RESPONSE TO PNEUMOCOCCAL INFECTION$103,508
R01 · FY2002 · AI
MUCOSAL DEFENSE BY IGA AGAINST S PNEUMONIAE$305,763
R01 · FY2001 · AI
DENTAL AMALGAMS, MERCURY$416,691
N01 · FY2000 · DE
MUCOSAL IMMUNITY TO HIV$375,348
N01 · FY2000 · DE